Immediate Impact
3 from Science/Nature 55 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Flavia Neri being referenced
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma
2015
Endolymphatic Immunotherapy in Inoperable Hepatocellular Carcinoma
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Flavia Neri | 367 | 217 | 100 | 189 | 65 | 922 | |
| M Iappelli | 320 | 242 | 107 | 147 | 41 | 791 | |
| Roy A. Axelsen | 223 | 98 | 47 | 149 | 40 | 1.1k | |
| Laśzló Kob́ori | 385 | 336 | 77 | 223 | 105 | 1.0k | |
| Lei Luo | 123 | 121 | 42 | 130 | 44 | 926 | |
| Shengli Wu | 287 | 124 | 119 | 158 | 43 | 869 | |
| Su-Kil Park | 204 | 84 | 136 | 239 | 79 | 1.1k | |
| Marie‐Claude Gagnieu | 93 | 222 | 34 | 259 | 61 | 843 | |
| P. Wolf | 322 | 276 | 65 | 250 | 40 | 779 | |
| Maximilian Jara | 364 | 423 | 43 | 491 | 48 | 927 | |
| Maciej Wójcicki | 520 | 405 | 91 | 149 | 69 | 839 |
All Works
Login with ORCID to disown or claim papers
Loading papers...